Furthermore, the introduction of artificial gain-of-function mutants such as STAT5AS710F into mice identified STAT5 as a putative oncogene capable of inducing tumor initiation in many hematopoietic cell types, independent of dysregulated upstream kinases11. This evidence concerns the gene STAT5B and neoplasm.